Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.4.1.288: galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase

This is an abbreviated version!
For detailed information about galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase, go to the full flat file.

Word Map on EC 2.4.1.288

Reaction

28 UDP-alpha-D-galactofuranose +

beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol
= 28 UDP +
[beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->6)]14-beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol

Synonyms

galactofuranosyl transferase 2, galactofuranosyltransferase, galactosyl transferase, GalTr, GlfT, GlfT2, LmjF.25.0010, LMJF_25_0010, LPG1, LPG1G, LPG1G2, LPG1L, Rv3808c

ECTree

     2 Transferases
         2.4 Glycosyltransferases
             2.4.1 Hexosyltransferases
                2.4.1.288 galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase

Inhibitors

Inhibitors on EC 2.4.1.288 - galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(1S,2S,3S,4S,5R)-1-[(1S)-1,2-dihydroxyethyl]-4-[[(furan-2-yl)methyl]amino]bicyclo[3.1.0]hexane-2,3-diol
UDP-Gal analogue, 82% inhibition at 4 mM
(2R,3R,4R,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl hydrogen ((E)-((3R,4R,5S)-5-((R)-1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene)fluoromethyl)phosphonate
-
(2R,3R,4R,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl hydrogen ((Z)-((3R,4R,5S)-5-((R)-1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene)fluoromethyl)phosphonate
-
(3S,4S)-3-(1,2-dihydroxyethyl)-4-hydroxy-1-(2-phenylethyl)tetrahydrothiophenium chloride
sulfonium ion compound as analogue of the donor substrate, uridine diphosphategalactofuranose. The compound contains moieties that mimic both galactofuranose and uridine diphosphate domains, and carries a permanent positive charge to mimic the oxocarbenium ion-like transition state. About 60% inhibition at 4 mM
(3S,4S)-3-(1,2-dihydroxyethyl)-4-hydroxy-1-[2-(4-nitrophenyl)ethyl]tetrahydrothiophenium bromide
sulfonium ion compound as analogue of the donor substrate, uridine diphosphategalactofuranose. The compound contains moieties that mimic both galactofuranose and uridine diphosphate domains, and carries a permanent positive charge to mimic the oxocarbenium ion-like transition state. About 50% inhibition at 4 mM
2-[(5E)-5-[(3,4-dichlorophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-(4-iodophenyl)propanoic acid
UDP-galactopyranose mutase inhibitor, binding energy value of -8.08 kcal/mol. Compound passes the ADME evaluation and the predicted toxicity evaluation
UDP-3''-deoxy-alpha-D-xylo-hexofuranose
-
68% inhibition at 1.25 mM
UDP-5''-O-methyl-alpha-D-galactofuranose
-
15% inhibition at 1.25 mM
UDP-5-deoxy-alpha-D-galactofuranose
-
10% inhibition at 1.25 mM
UDP-6''-O-methyl-alpha-D-galactofuranose
-
26% inhibition at 1.25 mM
UDP-alpha-D-arabinofuranose
-
less than 1% inhibition at 1.25 mM
additional information
-
not inhibited by UDP-2''-O-methyl-alpha-D-galactofuranose
-